Biotech Archives - Page 686 of 733

1 minute read

Gilead’s Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays

August 22, 11:25 AM

The European Commission has approved Gilead Sciences Inc’s (NASDAQ:GILD) lenacapavir for adults with multi-drug resistant HIV infection. The drug, branded as…

GILD

1 minute read

Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off

By Ragothaman Srinivasan

August 22, 11:17 AM

Cue Biopharma (NASDAQ: CUE) has dosed the first patient in a Phase 1 dose escalation study evaluating CUE-102 for the treatment of patients with Wilms' Tumor 1 (WT1)-positive recurrent/metastatic cancers.

CUE

1 minute read

Minerva Seeks FDA Approval For Schizophrenia Candidate

By Ragothaman Srinivasan

August 22, 10:51 AM

Minerva Neurosciences (NASDAQ: NERV) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for roluperidone in the treatment of negative symptoms for patients with schizophrenia.

NERV

1 minute read

Belite Bio Shares Gain On Initiation Of Late-Stage Retinal Disease Study

By Ragothaman Srinivasan

August 22, 10:23 AM

Belite Bio (NASDAQ: BLTE) has initiated enrollment for the U.S. Phase 3 clinical trial of its lead asset LBS-008 in patients with Stargardt Disease (STGD1), a progressively blinding disease with no approved treatment.

BLTE

1 minute read

UK Says Monkeypox Vaccines To Be Piloted In Smaller But ‘Equally Effective’ Doses

By Benzinga Newsdesk

August 22, 10:19 AM

-Reuters

AEMD

1 minute read

Moderna to Supply 12M Doses of Omicron-Adapted COVID-19 Booster To Canada

By Vandana Singh

August 22, 10:04 AM

Moderna Inc (NASDAQ:MRNA) will supply 12 million doses of its COVID-19 shot adapted to target the Omicron variant of the coronavirus…

MRNA

3 minute read

Salarius Pharmaceuticals Adds Two Mayo Clinic Sites To Its Ongoing Phase 1/2 Trial Of Seclidemstat As A Treatment For Ewing’s Sarcoma And FET-Rearranged Sarcomas

By Bill Haddad

August 22, 8:33 AM

Expands Trial to 17 U.S. Sites and 25 Locations Initiation of All Anticipated U.S. Trial Sites Largely Completed HOUSTON, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a

SLRX

2 minute read

Kronos Bio Announces First Patient Dosed In Phase 1b/2 Clinical Trial Of Lanraplenib In Combination With Gilteritinib In Acute Myeloid Leukemia

By Bill Haddad

August 22, 8:08 AM

Kronos Bio, Inc. (NASDAQ:KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that the first patient has been dosed in a Phase 1b/2 clinical trial of lanraplenib in

KRON

1 minute read

Minerva Neurosciences Submits New Drug Application To FDA For Roluperidone For Treatment Of Negative Symptoms In Patients With Schizophrenia

By Bill Haddad

August 22, 8:01 AM

Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that the company has

NERV

1 minute read

FDA Clears Insulet’s Omnipod 5 Automated Insulin Delivery System For Preschool Children

By Ragothaman Srinivasan

August 22, 7:39 AM

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D).

PODD